Cargando…

Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice

Brain cholesterol biosynthesis and cholesterol levels are reduced in mouse models of Huntington's disease (HD), suggesting that locally synthesized, newly formed cholesterol is less available to neurons. This may be detrimental for neuronal function, especially given that locally synthesized ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenza, Marta, Chen, Jane Y, Di Paolo, Eleonora, Ruozi, Barbara, Belletti, Daniela, Ferrari Bardile, Costanza, Leoni, Valerio, Caccia, Claudio, Brilli, Elisa, Di Donato, Stefano, Boido, Marina M, Vercelli, Alessandro, Vandelli, Maria A, Forni, Flavio, Cepeda, Carlos, Levine, Michael S, Tosi, Giovanni, Cattaneo, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693506/ https://www.ncbi.nlm.nih.gov/pubmed/26589247 http://dx.doi.org/10.15252/emmm.201505413

Ejemplares similares

Pitfalls in the detection of cholesterol in Huntington’s disease models
por: Marullo, Manuela, et al.
Publicado: (2012)

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
por: Birolini, Giulia, et al.
Publicado: (2023)

AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
por: Ruozi, Barbara, et al.
Publicado: (2011)

Striatal infusion of cholesterol promotes dose‐dependent behavioral benefits and exerts disease‐modifying effects in Huntington's disease mice
por: Birolini, Giulia, et al.
Publicado: (2020)

Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
por: Vilella, Antonietta, et al.
Publicado: (2015)

Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway
por: Barry, Joshua, et al.
Publicado: (2022)

Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders
por: Salvalaio, Marika, et al.
Publicado: (2016)

Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease
por: Cummings, Damian M, et al.
Publicado: (2010)

Development of Novel Zn(2+) Loaded Nanoparticles Designed for Cell-Type Targeted Drug Release in CNS Neurons: In Vitro Evidences
por: Grabrucker, Andreas M., et al.
Publicado: (2011)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice
por: Holley, Sandra M., et al.
Publicado: (2019)

Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

Quantitative comparison of the protein corona of nanoparticles with different matrices
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136]
por: Ottonelli, Ilaria, et al.
Publicado: (2023)

Early white matter pathology in the fornix of the limbic system in Huntington disease
por: Gabery, Sanaz, et al.
Publicado: (2021)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2016)

Genes and miRNAs as Hurdles and Promoters of Corticospinal Tract Regeneration in Spinal Cord Injury
por: Boido, Marina, et al.
Publicado: (2021)

Corticostriatal synaptic adaptations in Huntington’s disease
por: Plotkin, Joshua L., et al.
Publicado: (2015)

Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington’s Disease Mice
por: Botelho, Eliã P., et al.
Publicado: (2014)

Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022)

The Dual Nature of Onuf’s Nucleus: Neuroanatomical Features and Peculiarities, in Health and Disease
por: Schellino, Roberta, et al.
Publicado: (2020)

JNK Signaling Pathway Involvement in Spinal Cord Neuron Development and Death
por: Schellino, Roberta, et al.
Publicado: (2019)

Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
por: Oddone, Natalia, et al.
Publicado: (2020)

Calcium imaging: A versatile tool to examine Huntington’s disease mechanisms and progression
por: Barry, Joshua, et al.
Publicado: (2022)

PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
por: Hoyos-Ceballos, Gina P., et al.
Publicado: (2020)

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility
por: Chen, Jane Y., et al.
Publicado: (2013)

Pharmacological c-Jun NH(2)-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice
por: Schellino, Roberta, et al.
Publicado: (2018)

Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
por: Stanga, Serena, et al.
Publicado: (2020)

Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease
por: Besusso, Dario, et al.
Publicado: (2020)

Genetic mouse models of Huntington’s disease: focus on electrophysiological mechanisms
por: Cepeda, Carlos, et al.
Publicado: (2010)

Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Synaptic RTP801 contributes to motor-learning dysfunction in Huntington’s disease
por: Martín-Flores, Núria, et al.
Publicado: (2020)

Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington’s Disease?
por: Grosso Jasutkar, Hilary, et al.
Publicado: (2021)

Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model
por: Valsecchi, Valeria, et al.
Publicado: (2015)

Organotypic spinal cord cultures: An in vitro 3D model to preliminary screen treatments for spinal muscular atrophy
por: Boido, Marina, et al.
Publicado: (2021)

Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
por: Kim, Anya, et al.
Publicado: (2020)

Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis
por: Onur, Tarik Seref, et al.
Publicado: (2021)

Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum
por: Iuliano, Maria, et al.
Publicado: (2021)

Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6g43u6mk1inis04q3btlrnpcmt